AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 1654753 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mL of 0.5% bupivacaine (pH, 5.58 +/‐ 0.12)
Number of subjects: 40
Study 1654753 — intervention group
Group type: COMPARATOR
Intervention: 20 mL of 0.5% bupivacaine + 0.6 mL of 1.4% bicarbonate (pH, 6.53 +/‐ 0.06)
Number of subjects: 40
Study 7046412 — intervention group
Group type: EXPERIMENTAL
Intervention: Megestrol acetate (150 mg/m2 daily in three divided doses)
Number of subjects: 55
Study 7046412 — intervention group
Group type: COMPARATOR
Intervention: Tamoxifen (10 mg twice daily)
Number of subjects: 55
Study 31674902 — intervention group
Group type: EXPERIMENTAL
Intervention: THA with dual mobility cup (DMC)
Number of subjects: 60
Study 28231964 — intervention group
Group type: EXPERIMENTAL
Intervention: Ilizarov external fixator
Number of subjects: 27
Study 28231964 — intervention group
Group type: COMPARATOR
Intervention: Retrograde intramedullary nailing (IMN)
Number of subjects: 27
Study 26668108 — intervention group
Group type: EXPERIMENTAL
Intervention: Salicylic acid plasters
Number of subjects: 201
Study 26668108 — intervention group
Group type: COMPARATOR
Intervention: Scalpel debridement (Control)
Number of subjects: 201
Study 26668108 — intervention group
Group type: EXPERIMENTAL
Intervention: Dorsal/interdigital (ID) corns
Number of subjects: 201
Study 26668108 — intervention group
Group type: EXPERIMENTAL
Intervention: Plantar corns
Number of subjects: 201
Study 26668108 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of life (QoL) measures
Number of subjects: 201
Study 26668108 — intervention group
Group type: EXPERIMENTAL
Intervention: Manchester Foot Pain and Disability Index (MFPDI)
Number of subjects: 201
Study 24533507 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical valproic acid (sodium valproate, 8.3%)
Number of subjects: 40
Study 24533507 — intervention group
Group type: COMPARATOR
Intervention: Placebo spray
Number of subjects: 40
Study 22989342 — intervention group
Group type: EXPERIMENTAL
Intervention: More frequent follow-up (every 4 to 6 weeks)
Number of subjects: 30
Study 22989342 — intervention group
Group type: COMPARATOR
Intervention: Standard follow-up (month intervals based on age in years)
Number of subjects: 30
Study 22989342 — intervention group
Group type: EXPERIMENTAL
Intervention: More frequent follow-up (every 4 to 6 weeks) without epidemiology, intention to treat analysis (ITT)
Number of subjects: 30
Study 22989342 — intervention group
Group type: COMPARATOR
Intervention: Standard follow-up (month intervals based on age in years) without epidemiology, intention to treat analysis (ITT)
Number of subjects: 30
Study 22989342 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental survey responses
Number of subjects: 30
Study 20014522 — intervention group
Group type: EXPERIMENTAL
Intervention: Male participants rating themselves on physical attractiveness when facing male opponents
Number of subjects: 0
Study 20014522 — intervention group
Group type: EXPERIMENTAL
Intervention: Male participants rating themselves on physical attractiveness when facing female opponents
Number of subjects: 0
Study 20014522 — intervention group
Group type: EXPERIMENTAL
Intervention: Male participants' self-ratings of physical attractiveness
Number of subjects: 0
Study 20014522 — intervention group
Group type: EXPERIMENTAL
Intervention: Female participants' self-ratings of physical attractiveness
Number of subjects: 0
Study 17972591 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled corticosteroid and as-needed beta-agonist
Number of subjects: 60
Study 17972591 — intervention group
Group type: COMPARATOR
Intervention: Dongchong xiacao capsule plus inhaled corticosteroid and as-needed beta-agonist
Number of subjects: 60
Study 14760514 — intervention group
Group type: EXPERIMENTAL
Intervention: Lecithin (1.6 g/day)
Number of subjects: 400
Study 14760514 — intervention group
Group type: EXPERIMENTAL
Intervention: Carnitine (500 mg/day)
Number of subjects: 400
Study 14760514 — intervention group
Group type: EXPERIMENTAL
Intervention: Carnitine plus lecithin
Number of subjects: 400
Study 14760514 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose drink
Number of subjects: 400
Study 14760514 — intervention group
Group type: COMPARATOR
Intervention: Placebo drink
Number of subjects: 400
Study 14760514 — intervention group
Group type: EXPERIMENTAL
Intervention: Carnitine and glucose drink
Number of subjects: 400
Study 14760514 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 400
Study 11641684 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical evacuation of the uterus with misoprostol
Number of subjects: 218
Study 11641684 — intervention group
Group type: COMPARATOR
Intervention: Routine surgical evacuation of the uterus
Number of subjects: 218
Study 9589295 — intervention group
Group type: EXPERIMENTAL
Intervention: CD patients with long ileal resections
Number of subjects: 14
Study 9589295 — intervention group
Group type: EXPERIMENTAL
Intervention: CD patients with short ileal resections
Number of subjects: 14
Study 9589295 — intervention group
Group type: EXPERIMENTAL
Intervention: CD patients with long or short ileal resections
Number of subjects: 14
Study 9589295 — intervention group
Group type: COMPARATOR
Intervention: Healthy subjects
Number of subjects: 14
Study 7805564 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperfractionated irradiation (HF) with 1.15‐1.25Gy per fraction, twice daily, total doses of 69.6 +/- 2.1Gy
Number of subjects: 109
Study 7805564 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperfractionated irradiation (HF)
Number of subjects: 109
Study 7805564 — intervention group
Group type: COMPARATOR
Intervention: Conventional irradiation (CF) with 1.8‐2.0Gy per fraction, once a day, total doses of 63.9 +/- 1.1Gy
Number of subjects: 109
Study 7805564 — intervention group
Group type: COMPARATOR
Intervention: Conventional irradiation (CF)
Number of subjects: 109
Study 3385871 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefamandole
Number of subjects: 25
Study 3385871 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 31968180 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual wavelength Er,Cr:YSGG (2 W, 20 Hz, 50 μs) and diode 940 nm (2 W, 50% DC)
Number of subjects: 40
Study 31968180 — intervention group
Group type: EXPERIMENTAL
Intervention: XP‐Endoshaper and finisher with EDTA 17%
Number of subjects: 40
Study 31968180 — intervention group
Group type: COMPARATOR
Intervention: Dual wavelength Er,Cr:YSGG (1.25 W, 50 Hz, 50 μs) and diode 940 nm (2 W, 50% DC)
Number of subjects: 40
Study 31968180 — intervention group
Group type: COMPARATOR
Intervention: Negative control irrigated with distilled water
Number of subjects: 40
Study 31968180 — intervention group
Group type: COMPARATOR
Intervention: Positive control irrigated with EDTA 17% and a final rinse of NaOCl 3%
Number of subjects: 40
Study 30241913 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual lymph drainage (MLD) in addition to information and exercise therapy
Number of subjects: 160
Study 30241913 — intervention group
Group type: COMPARATOR
Intervention: Control group (no MLD)
Number of subjects: 160
Study 29113036 — intervention group
Group type: EXPERIMENTAL
Intervention: Stationary cycle (CYC)
Number of subjects: 21
Study 29113036 — intervention group
Group type: COMPARATOR
Intervention: Traditional sit (SIT)
Number of subjects: 21
Study 26303626 — intervention group
Group type: EXPERIMENTAL
Intervention: Overnight supplementary oxygen
Number of subjects: 20
Study 26303626 — intervention group
Group type: EXPERIMENTAL
Intervention: Auto-adjusting continuous positive airways pressure (APAP)
Number of subjects: 20
Study 22710258 — intervention group
Group type: EXPERIMENTAL
Intervention: Healing Touch (HT)
Number of subjects: 9
Study 22710258 — intervention group
Group type: COMPARATOR
Intervention: Reading/play activity (Control)
Number of subjects: 9
Study 21489346 — intervention group
Group type: EXPERIMENTAL
Intervention: THC
Number of subjects: 23
Study 18779029 — intervention group
Group type: EXPERIMENTAL
Intervention: Group-based DPP lifestyle intervention by the YMCA
Number of subjects: 92
Study 18779029 — intervention group
Group type: COMPARATOR
Intervention: Brief counseling alone (control)
Number of subjects: 92
Study 16736081 — intervention group
Group type: COMPARATOR
Intervention: Neutral birthday greeting
Number of subjects: 994
Study 16736081 — intervention group
Group type: EXPERIMENTAL
Intervention: Harm reduction information
Number of subjects: 994
Study 16736081 — intervention group
Group type: EXPERIMENTAL
Intervention: Messages from the B.R.A.D. Foundation
Number of subjects: 994
Study 16736081 — intervention group
Group type: EXPERIMENTAL
Intervention: Social norming messages
Number of subjects: 994
Study 16736081 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of harm reduction and social norming messages
Number of subjects: 994
Study 12880623 — intervention group
Group type: EXPERIMENTAL
Intervention: Child-targeted nutrition counselling for parents over 6.5 years
Number of subjects: 187
Study 12880623 — intervention group
Group type: COMPARATOR
Intervention: Control group (no child-targeted nutrition counselling)
Number of subjects: 187
Study 11494182 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 18
Study 11494182 — intervention group
Group type: EXPERIMENTAL
Intervention: Trager
Number of subjects: 18
Study 9566274 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant IFN alpha 2a
Number of subjects: 96
Study 9566274 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant IFN alpha 2b
Number of subjects: 96
Study 9566274 — intervention group
Group type: EXPERIMENTAL
Intervention: Lymphoblastoid IFN alpha
Number of subjects: 96
Study 9566274 — intervention group
Group type: EXPERIMENTAL
Intervention: Leukocyte IFN alpha
Number of subjects: 96
Study 9566274 — intervention group
Group type: COMPARATOR
Intervention: Control group (untreated hepatitis C patients)
Number of subjects: 96
Study 7761019 — intervention group
Group type: EXPERIMENTAL
Intervention: Betamethasone 0.1 mg/kg administered 10 min after continuous infusion of vecuronium
Number of subjects: 20
Study 7761019 — intervention group
Group type: EXPERIMENTAL
Intervention: Vecuronium 0.08 mg/kg bolus followed by continuous infusion of 0.4‐0.5 micrograms/kg/min
Number of subjects: 20
Study 3288070 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin 500 mg tid for seven days
Number of subjects: 51
Study 3288070 — intervention group
Group type: COMPARATOR
Intervention: Control (no aspirin)
Number of subjects: 51
Study 31965579 — intervention group
Group type: EXPERIMENTAL
Intervention: Obeticholic acid (OCA) 25 mg orally once daily
Number of subjects: 78
Study 31965579 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78
Study 31965579 — intervention group
Group type: EXPERIMENTAL
Intervention: Obeticholic acid (OCA)
Number of subjects: 78
Study 31965579 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI-PDFF responders (30% or greater decline)
Number of subjects: 78
Study 30670515 — intervention group
Group type: EXPERIMENTAL
Intervention: History of 1 miscarriage
Number of subjects: 977
Study 30670515 — intervention group
Group type: EXPERIMENTAL
Intervention: History of ≥2 miscarriages
Number of subjects: 977
Study 30670515 — intervention group
Group type: COMPARATOR
Intervention: Only live birth
Number of subjects: 977
Study 27864638 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (4 mg kg‐1)
Number of subjects: 7
Study 27864638 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study 25277169 — intervention group
Group type: EXPERIMENTAL
Intervention: 30%EMGpeak (34%MVC)
Number of subjects: 40
Study 25277169 — intervention group
Group type: EXPERIMENTAL
Intervention: 20%EMGpeak (23%MVC)
Number of subjects: 40
Study 25277169 — intervention group
Group type: EXPERIMENTAL
Intervention: IET (combined for females)
Number of subjects: 40
Study 25277169 — intervention group
Group type: EXPERIMENTAL
Intervention: IET (combined for males)
Number of subjects: 40
Study 23963274 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc supplementation (2 mg/kg/day for 60 days)
Number of subjects: 38
Study 23963274 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 38
Study 21598858 — intervention group
Group type: EXPERIMENTAL
Intervention: Analogy-guided learning activities incorporated into weekly group discussions, reflective journal writing, and questioning with clinical faculty.
Number of subjects: 0
Study 21598858 — intervention group
Group type: COMPARATOR
Intervention: Traditional activities (control group).
Number of subjects: 0
Study 19090531 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral therapy (BT) including Individualized Sleep Promotion Plan (ISPP) with modified stimulus control, modified sleep restriction, relaxation therapy, and sleep hygiene.
Number of subjects: 219
Study 19090531 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral therapy (BT)
Number of subjects: 219
Study 19090531 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving healthy eating information and attention.
Number of subjects: 219
Study 16720830 — intervention group
Group type: EXPERIMENTAL
Intervention: Hematide 0.1 mg/kg
Number of subjects: 28
Study 16720830 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 15464488 — intervention group
Group type: COMPARATOR
Intervention: Papaverine injection before harvest (Group 2)
Number of subjects: 58
Study 15464488 — intervention group
Group type: EXPERIMENTAL
Intervention: Papaverine delivery after dissection (Group 3)
Number of subjects: 58
Study 15464488 — intervention group
Group type: COMPARATOR
Intervention: Control group (Group 1)
Number of subjects: 58
Study 11779325 — intervention group
Group type: EXPERIMENTAL
Intervention: Mastoid obliteration using a temporoparietal fascial flap
Number of subjects: 60
Study 11779325 — intervention group
Group type: COMPARATOR
Intervention: Conservative treatment and observation
Number of subjects: 60
Study 9025770 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-fluorouracil (375 mg/m2 per day) and leucovorin (200 mg/m2 per day) administered intravenously (days 1-5) with levamisole (30 to 470 mg/m2 per day) administered orally (days 1-3 and 15-17)
Number of subjects: 38
Study 9025770 — intervention group
Group type: COMPARATOR
Intervention: 5-fluorouracil and leucovorin alone
Number of subjects: 38
Study 9025770 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-fluorouracil and leucovorin with levamisole
Number of subjects: 38
Study 8513037 — intervention group
Group type: EXPERIMENTAL
Intervention: Late melatonin (5 mg for 5 days after 3 days of placebo)
Number of subjects: 52
Study 8513037 — intervention group
Group type: EXPERIMENTAL
Intervention: Early melatonin (5 mg started 3 days prior to arrival until 5 days after return home)
Number of subjects: 52
Study 8513037 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 31809432 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine pessary care (office visits every 12 weeks)
Number of subjects: 130
Study 31809432 — intervention group
Group type: COMPARATOR
Intervention: Extended pessary care (office visits every 24 weeks)
Number of subjects: 130
Study 30874251 — intervention group
Group type: EXPERIMENTAL
Intervention: Toothpaste containing arginine (ProRelief, Colgate)
Number of subjects: 50
Study 30874251 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoride toothpaste (Pronamel, Sensodyne GlaxoSmithKlein)
Number of subjects: 50
Study 30874251 — intervention group
Group type: EXPERIMENTAL
Intervention: Tooth mousse containing casein phosphopeptide‐amorphous calcium phosphate (CPP‐ACP) (Recaldent, GC)
Number of subjects: 50
Study 30874251 — intervention group
Group type: EXPERIMENTAL
Intervention: Toothpaste (Restore, Dr. Collins) containing bioactive glass (NovaMin, GlaxoSmithKlein)
Number of subjects: 50
Study 30874251 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 50
Study 27660924 — intervention group
Group type: EXPERIMENTAL
Intervention: Quiet routine protocol (intervention)
Number of subjects: 0
Study 27660924 — intervention group
Group type: COMPARATOR
Intervention: Control (standard ICU environment)
Number of subjects: 0
Study 25898217 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention
Number of subjects: 51
Study 25898217 — intervention group
Group type: COMPARATOR
Intervention: Financial counseling
Number of subjects: 51
Study 23722592 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant adenoviral human p53 gene therapy (rAd‐p53) with radiotherapy (60 Gy)
Number of subjects: 107
Study 23722592 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG) with radiotherapy (60 Gy)
Number of subjects: 107
Study 21775930 — intervention group
Group type: EXPERIMENTAL
Intervention: sirolimus‐MMF
Number of subjects: 122
Study 21775930 — intervention group
Group type: COMPARATOR
Intervention: tacrolimus‐MMF
Number of subjects: 122
Study 18323730 — intervention group
Group type: EXPERIMENTAL
Intervention: Postpartum breast-feeding support by nurses (telephone calls once a week for 4 weeks postpartum, then once a month for 16 weeks postpartum)
Number of subjects: 55
Study 18323730 — intervention group
Group type: COMPARATOR
Intervention: Control group (telephone call at postpartum week 4, 8, 12, and 16)
Number of subjects: 55
Study 16525604 — intervention group
Group type: EXPERIMENTAL
Intervention: Sonic electric toothbrush
Number of subjects: 50
Study 16525604 — intervention group
Group type: COMPARATOR
Intervention: Traditional manual toothbrush (control group)
Number of subjects: 50
Study 12938264 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-FU-based chemotherapy
Number of subjects: 5365
Study 12938264 — intervention group
Group type: EXPERIMENTAL
Intervention: gemcitabine
Number of subjects: 5365
Study 12938264 — intervention group
Group type: COMPARATOR
Intervention: 5-FU or other cytotoxic agent alone
Number of subjects: 5365
Study 12938264 — intervention group
Group type: COMPARATOR
Intervention: various 5-FU combinations
Number of subjects: 5365
Study 11099446 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional MRI (fMRI) during passive movement task
Number of subjects: 17
Study 11099446 — intervention group
Group type: EXPERIMENTAL
Intervention: Median nerve stimulation of the hemiplegic hand
Number of subjects: 17
Study 11099446 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioural tests (grip strength, double simultaneous stimulation, joint position sense)
Number of subjects: 17
Study 11099446 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioural tests
Number of subjects: 17
Study 11099446 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall findings
Number of subjects: 17
Study 8783704 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipenem
Number of subjects: 79
Study 8783704 — intervention group
Group type: EXPERIMENTAL
Intervention: Ampicillin/sulbactam
Number of subjects: 79
Study 8783704 — intervention group
Group type: COMPARATOR
Intervention: DIC presence
Number of subjects: 79
Study 8783704 — intervention group
Group type: COMPARATOR
Intervention: Inappropriate antimicrobial treatment
Number of subjects: 79
Study 8783704 — intervention group
Group type: COMPARATOR
Intervention: Overall mortality
Number of subjects: 79
Study 1385761 — intervention group
Group type: EXPERIMENTAL
Intervention: Toremifene 200 mg/m2 p.o. daily
Number of subjects: 19
Study 1385761 — intervention group
Group type: EXPERIMENTAL
Intervention: Toremifene 300 mg/m2 p.o. daily
Number of subjects: 19
Study 1385761 — intervention group
Group type: EXPERIMENTAL
Intervention: Toremifene 400 mg/m2 p.o. daily
Number of subjects: 19
Study 1385761 — intervention group
Group type: EXPERIMENTAL
Intervention: Toremifene (all doses)
Number of subjects: 19
Study 1385761 — intervention group
Group type: EXPERIMENTAL
Intervention: Toremifene pharmacokinetics
Number of subjects: 19
Study 6384847 — intervention group
Group type: EXPERIMENTAL
Intervention: Nova T
Number of subjects: 1865
Study 6384847 — intervention group
Group type: COMPARATOR
Intervention: Copper T 200
Number of subjects: 1865
Study 31665933 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-monitoring combined with earning monetary incentives for behavior
Number of subjects: 0
Study 31665933 — intervention group
Group type: COMPARATOR
Intervention: Self-monitoring of fruit and vegetable consumption
Number of subjects: 0
Study 31665933 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher stress levels
Number of subjects: 0
Study 31665933 — intervention group
Group type: EXPERIMENTAL
Intervention: Incentive condition
Number of subjects: 0
Study 31665933 — intervention group
Group type: EXPERIMENTAL
Intervention: Time effect
Number of subjects: 0
Study 30663156 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet and exercise intervention (1-h weekly diet sessions and 75-min bi-weekly physical activity sessions)
Number of subjects: 37
Study 29746725 — intervention group
Group type: EXPERIMENTAL
Intervention: DS-2969b (6 mg, 20 mg, 60 mg, 200 mg, 400 mg, 600 mg)
Number of subjects: 48
Study 29746725 — intervention group
Group type: EXPERIMENTAL
Intervention: DS-2969b (60 mg or higher)
Number of subjects: 48
Study 29746725 — intervention group
Group type: EXPERIMENTAL
Intervention: DS-2969b
Number of subjects: 48
Study 29746725 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 26881019 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased urinary total polyphenol excretion (TPE)
Number of subjects: 573
Study 25257875 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin (5 mU·kg(‐1)·min(‐1))
Number of subjects: 18
Study 25257875 — intervention group
Group type: COMPARATOR
Intervention: Control (standard metabolic care)
Number of subjects: 18
Study 22157800 — intervention group
Group type: EXPERIMENTAL
Intervention: DVD intervention
Number of subjects: 216
Study 22157800 — intervention group
Group type: EXPERIMENTAL
Intervention: Live intervention
Number of subjects: 216
Study 22157800 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined social contact group (DVD/live)
Number of subjects: 216
Study 22157800 — intervention group
Group type: COMPARATOR
Intervention: Lecture control
Number of subjects: 216
Study 20415595 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV-positive glans/coronal sulcus specimens
Number of subjects: 2168
Study 20415595 — intervention group
Group type: COMPARATOR
Intervention: HPV-negative glans/coronal sulcus specimens
Number of subjects: 2168
Study 17998497 — intervention group
Group type: EXPERIMENTAL
Intervention: Test results management tool embedded in electronic health record
Number of subjects: 570
Study 15127089 — intervention group
Group type: EXPERIMENTAL
Intervention: Vegetable juice supplementation (one can daily)
Number of subjects: 23
Study 15127089 — intervention group
Group type: EXPERIMENTAL
Intervention: Vegetable juice supplementation
Number of subjects: 23
Study 15127089 — intervention group
Group type: COMPARATOR
Intervention: Placebo (orange soda, placebo pill daily)
Number of subjects: 23
Study 15127089 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23